Calithera Biosciences, Inc. (CALA) Financials

CALA Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2022 28.7 million 8.3 million
Sept. 30, 2022 37.1 million 10.7 million
June 30, 2022 45.6 million 10.3 million
March 31, 2022 50.2 million 53.4 million

CALA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2022 -8.6 million 936000
Sept. 30, 2022 -7.7 million 939000
June 30, 2022 -11.4 million 975000
March 31, 2022 -16.0 million 1.2 million

CALA Net Income

No data available :(

CALA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2022 25.5 million - 1.7 million
Sept. 30, 2022 34.1 million - 2.0 million
June 30, 2022 41.8 million - 2.4 million
March 31, 2022 44.7 million - 2.7 million

CALA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2022 5.0 million
Sept. 30, 2022 4.9 million
June 30, 2022 5.7 million
March 31, 2022 3.9 million

CALA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2022 23000 4.8 million 2.6 million -
Sept. 30, 2022 110000 6.4 million 3.1 million -
June 30, 2022 110000 7.8 million 3.6 million -
March 31, 2022 110000 9.6 million 4.3 million -

CALA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2022 - 357000
Sept. 30, 2022 - -
June 30, 2022 - -
March 31, 2022 - -

CALA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CALA

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -2.65 USD

P/E Ratio: -3.31

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 883600

Ebitda: -6.6 million

Market Capitalization: 1949

Links: